乐观
$2.58
情景价格
$1.930
-0.156 (-8.10%)收盘时
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.
B. Riley
$4
2026-09-22
B. Riley
2026-09-22
目标价
$4
B. Riley
—
2026-09-03
B. Riley
2026-09-03
目标价
—
B. Riley
$3
2026-04-23
B. Riley
2026-04-23
目标价
$3
Maxim Group
—
2024-10-16
Maxim Group
2024-10-16
目标价
—
Roth MKM
$24
2024-03-05
Roth MKM
2024-03-05
目标价
$24
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

North Korea Denies Links to Binance Hack Allegations

Solana Company Designated as Strategic Enterprise by Hong Kong Government

Solana Company Announces Governance Voting Positions Ahead of SGPs

Solana Co Reports Q2 2026 Earnings with Mixed Results

Solana Company Reports Larger Than Expected Quarterly Loss
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders. It operates in the Financials sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).
Helius Medical Technologies Inc (HSDT) is not a good buy right now due to its current price of $2.015 and a very low RSI of 21.258, indicating oversold conditions. The stock has also seen a significant decline of 55.71% over the past year, which raises concerns about its long-term viability. While the forward P/E is 0, suggesting potential for future earnings, the recent performance and negative sentiment surrounding the stock indicate that it may not be a suitable investment at this time.
1 analysts cover HSDT: 1 rate it Buy, 0 Hold and 0 Sell.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。